As in the SMART trial, early hemodynamic differences have yet to result in a clinical impact—but it may just be a matter of ...

This can be an important add-on to echocardiography in patients with a borderline need for intervention, researchers say.

For patients with asymptomatic severe aortic stenosis, transcatheter aortic valve replacement was superior to clinical ...

Find out why staging TAVI and PCI lowers risk in complex heart cases - read the latest insights from the ASCoP registry.

The Road to Gold (RTG) chairman Hannah Yeoh has clarified that the 16 athletes chosen are not obligated to join the national elite sports programme, which is aimed to secure Malaysia’s first ...

In the EARLY TAVR trial, which informed the approval, patients with asymptomatic severe aortic stenosis were randomly assigned to either TAVR or watchful waiting. During a median follow-up of 3.8 ...

MONDAY, May 5, 2025 (HealthDay News) -- The U.S. Food and Drug Administration has approved the SAPIEN 3 platform, a transcatheter aortic valve replacement (TAVR) therapy, for patients with severe ...

for patients with severe aortic stenosis without symptoms. The approval is the first for TAVR in asymptomatic patients. In the EARLY TAVR trial, which informed the approval, patients with asymptomatic ...